newsfilter
← Latest News
Business Wire·

CytRx to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced that Steven A. Kriegsman, the Company's Cha